Search and Browse
Download
Enter Data
| Reaction Details | |||
|---|---|---|---|
 | Report a problem with these data | ||
| Target | Mitogen-activated protein kinase 14 | ||
| Ligand | BDBM50347105 | ||
| Substrate/Competitor | n/a | ||
| Meas. Tech. | ChEMBL_752994 (CHEMBL1798818) | ||
| IC50 | 7±n/a nM | ||
| Citation |  Selness, SR; Boehm, TL; Walker, JK; Devadas, B; Durley, RC; Kurumbail, R; Shieh, H; Xing, L; Hepperle, M; Rucker, PV; Jerome, KD; Benson, AG; Marrufo, LD; Madsen, HM; Hitchcock, J; Owen, TJ; Christie, L; Promo, MA; Hickory, BS; Alvira, E; Naing, W; Blevis-Bal, R; Devraj, RV; Messing, D; Schindler, JF; Hirsch, J; Saabye, M; Bonar, S; Webb, E; Anderson, G; Monahan, JB Design, synthesis and activity of a potent, selective series of N-aryl pyridinone inhibitors of p38 kinase. Bioorg Med Chem Lett21:4059-65 (2011) [PubMed] Article | ||
| More Info.: | Get all data from this article, Assay Method | ||
| Mitogen-activated protein kinase 14 | |||
| Name: | Mitogen-activated protein kinase 14 | ||
| Synonyms: | CSAID-binding protein | CSBP | CSBP1 | CSBP2 | CSPB1 | Cytokine suppressive anti-inflammatory drug-binding protein | MAP kinase 14 | MAP kinase MXI2 | MAP kinase p38 alpha | MAPK 14 | MAPK14 | MAX-interacting protein 2 | MK14_HUMAN | MXI2 | Mitogen-activated protein kinase p38 alpha | SAPK2A | Stress-activated protein kinase 2a | p38 MAP kinase alpha/beta | ||
| Type: | Serine/threonine-protein kinase | ||
| Mol. Mass.: | 41286.76 | ||
| Organism: | Homo sapiens (Human) | ||
| Description: | Q16539 | ||
| Residue: | 360 | ||
| Sequence: |
| ||
| BDBM50347105 | |||
| n/a | |||
| Name | BDBM50347105 | ||
| Synonyms: | CHEMBL1797208 | ||
| Type | Small organic molecule | ||
| Emp. Form. | C21H16BrF4NO4 | ||
| Mol. Mass. | 502.254 | ||
| SMILES | Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1c(F)cc(OCCO)cc1F |(2.39,2.52,;1.06,1.75,;-.27,2.53,;-1.6,1.75,;-2.94,2.52,;-4.27,1.74,;-5.61,2.51,;-6.93,1.73,;-8.26,2.49,;-8.27,4.04,;-9.61,4.8,;-6.94,4.81,;-5.6,4.05,;-4.27,4.82,;-1.6,.21,;-2.93,-.56,;-.27,-.55,;-.27,-2.09,;1.06,.21,;2.39,-.56,;3.71,.21,;3.71,1.75,;5.05,-.56,;5.05,-2.11,;6.38,-2.88,;7.72,-2.11,;9.05,-2.88,;10.38,-2.11,;3.71,-2.87,;2.38,-2.1,;1.04,-2.87,)| | ||
| Structure | 
| ||